Healthy volunteers needed to test safety of experimental drug BI 3804379
NCT ID NCT06575400
First seen Apr 02, 2026 · Last updated Apr 27, 2026 · Updated 5 times
Summary
This early-stage trial tests the safety and how the body handles a new drug called BI 3804379. About 106 healthy adults aged 18 to 65 will receive either the drug or a placebo as a shot under the skin. The study aims to find any side effects and measure drug levels in the blood, with no direct health benefit to participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
SGS Life Science Services - Clinical Research
RECRUITINGEdegem, 2650, Belgium
Conditions
Explore the condition pages connected to this study.